P. Ernst

First name
Last name
Brunetti, V. C., St-Jean, A., Dell'Aniello, S., Fisher, A., H. Y. Yu, O., Bugden, S. C., et al. (2022). Characteristics of new users of recent antidiabetic drugs in Canada and the United Kingdom. Bmc Endocr Disord, 22, 241. http://doi.org/10.1186/s12902-022-01140-1
Suissa, S., Dell'Aniello, S., & Ernst, P. (2022). Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety. Int J Chron Obstruct Pulmon Dis, 17, 1975-1986. http://doi.org/10.2147/copd.s378486
Suissa, S., Dell'Aniello, S., & Ernst, P. (2022). Discontinuation of Inhaled Corticosteroids from Triple Therapy in COPD: Effects on Major Outcomes in Real World Clinical Practice. Copd, 19, 133-141. http://doi.org/10.1080/15412555.2022.2045265
Suissa, S., Dell'Aniello, S., & Ernst, P. (2022). Fluticasone-Based versus Budesonide-Based Triple Therapies in COPD: Real-World Comparative Effectiveness and Safety. Copd, 19, 109-117. http://doi.org/10.1080/15412555.2022.2035705
Filion, K. B., Delaney, J. A., Brophy, J. M., Ernst, P., & Suissa, S. (2007). The impact of over-the-counter simvastatin on the number of statin prescriptions in the United Kingdom: a view from the General Practice Research Database. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.1314
Ernst, P., Dell'Aniello, S., Mikaeloff, Y., & Suissa, S. (2011). Risk of herpes zoster in patients prescribed inhaled corticosteroids: a cohort study. BMC Pulm Med. http://doi.org/10.1186/1471-2466-11-59
Ernst, P., Renoux, C., Dell'Aniello, S., & Suissa, S. (2012). Pramipexole use and the risk of pneumonia. BMC Neurol. http://doi.org/10.1186/1471-2377-12-113
Dormuth, C. R., Hemmelgarn, B. R., Paterson, J. M., James, M. T., Teare, G. F., Raymond, C. B., et al. (2013). Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases. Bmj. http://doi.org/10.1136/bmj.f880
Filion, K. B., Chateau, D., Targownik, L. E., Gershon, A., Durand, M., Tamim, H., et al. (2014). Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis. Gut. http://doi.org/10.1136/gutjnl-2013-304738
Renoux, C., Lix, L. M., Patenaude, V., Bresee, L. C., Paterson, J. M., Lafrance, J. P., et al. (2015). Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis. Clin J Am Soc Nephrol. http://doi.org/10.2215/cjn.11271114